February 2018 Issue

GO TO FULL ISSUE

MED UPDATES

Adlyxine
lixisenatide
An injectable GLP-1 agonist for type 2 diabetes.

Ozempic
semaglutide
An injectable GLP-1 agonist for type 2 diabetes.

Akynzeo
palonosetron/netupitant
An oral combination formulation for preventing chemotherapy-associated nausea and vomiting.

MORE MED UPDATES